Evolutionary histories of breast cancer and related clones.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 04 07 2022
accepted: 15 06 2023
medline: 18 8 2023
pubmed: 27 7 2023
entrez: 26 7 2023
Statut: ppublish

Résumé

Recent studies have documented frequent evolution of clones carrying common cancer mutations in apparently normal tissues, which are implicated in cancer development

Identifiants

pubmed: 37495687
doi: 10.1038/s41586-023-06333-9
pii: 10.1038/s41586-023-06333-9
pmc: PMC10432280
doi:

Substances chimiques

AKT1 protein, human EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

607-614

Informations de copyright

© 2023. The Author(s).

Références

Kakiuchi, N. & Ogawa, S. Clonal expansion in non-cancer tissues. Nat. Rev. Cancer 21, 239–256 (2021).
pubmed: 33627798 doi: 10.1038/s41568-021-00335-3
Yokoyama, A. et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature 565, 312–317 (2019).
pubmed: 30602793 doi: 10.1038/s41586-018-0811-x
Kakiuchi, N. et al. Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis. Nature 577, 260–265 (2020).
pubmed: 31853061 doi: 10.1038/s41586-019-1856-1
Lawson, A. R. J. et al. Extensive heterogeneity in somatic mutation and selection in the human bladder. Science 370, 75–82 (2020).
pubmed: 33004514 doi: 10.1126/science.aba8347
Ng, S. W. K. et al. Convergent somatic mutations in metabolism genes in chronic liver disease. Nature 598, 473–478 (2021).
pubmed: 34646017 doi: 10.1038/s41586-021-03974-6
Fowler, J. C. et al. Selection of oncogenic mutant clones in normal human skin varies with body site. Cancer Discov. 11, 340–361 (2021).
pubmed: 33087317 doi: 10.1158/2159-8290.CD-20-1092
Ganz, J. et al. Rates and patterns of clonal oncogenic mutations in the normal human brain. Cancer Discov. 12, 172–185 (2022).
pubmed: 34389641 doi: 10.1158/2159-8290.CD-21-0245
Reiter, J. G. et al. An analysis of genetic heterogeneity in untreated cancers. Nat. Rev. Cancer 19, 639–650 (2019).
pubmed: 31455892 pmcid: 6816333 doi: 10.1038/s41568-019-0185-x
Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994–1007 (2012).
pubmed: 22608083 pmcid: 3428864 doi: 10.1016/j.cell.2012.04.023
Yates, L. R. et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21, 751–759 (2015).
pubmed: 26099045 pmcid: 4500826 doi: 10.1038/nm.3886
Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature 520, 353–357 (2015).
pubmed: 25830880 pmcid: 4413032 doi: 10.1038/nature14347
Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306–313 (2012).
pubmed: 22258609 pmcid: 3367003 doi: 10.1038/nature10762
Makohon-Moore, A. P. et al. Precancerous neoplastic cells can move through the pancreatic ductal system. Nature 561, 201–205 (2018).
pubmed: 30177826 pmcid: 6342205 doi: 10.1038/s41586-018-0481-8
Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
pubmed: 33538338 doi: 10.3322/caac.21660
Heer, E. et al. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Global Health 8, e1027–e1037 (2020).
pubmed: 32710860 doi: 10.1016/S2214-109X(20)30215-1
Newburger, D. E. et al. Genome evolution during progression to breast cancer. Genome Res. 23, 1097–1108 (2013).
pubmed: 23568837 pmcid: 3698503 doi: 10.1101/gr.151670.112
Ang, D. C. et al. Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions. Mod. Pathol. 27, 740–750 (2014).
pubmed: 24186142 doi: 10.1038/modpathol.2013.197
Troxell, M. L. et al. Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions. Mod. Pathol. 25, 930–937 (2012).
pubmed: 22460814 doi: 10.1038/modpathol.2012.55
de Boer, M. et al. Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplification. Mod. Pathol. 31, 1816–1833 (2018).
pubmed: 29976944 doi: 10.1038/s41379-018-0099-2
Washington, C., Dalbègue, F., Abreo, F., Taubenberger, J. K. & Lichy, J. H. Loss of heterozygosity in fibrocystic change of the breast. Am. J. Pathol. 157, 323–329 (2000).
pubmed: 10880402 pmcid: 1850200 doi: 10.1016/S0002-9440(10)64543-9
Roman, M. et al. Long-term risk of breast cancer after diagnosis of benign breast disease by screening mammography. Int. J. Environ. Res. Public Health https://doi.org/10.3390/ijerph19052625 (2022).
Amin, A. L. & Wagner, J. L. Contemporary management of atypical breast lesions identified on percutaneous biopsy: a narrative review. Annal. Breast Surg. 5, 9 (2021).
doi: 10.21037/abs-20-117
Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94–101 (2020).
pubmed: 32025018 pmcid: 7054213 doi: 10.1038/s41586-020-1943-3
Alexandrov, L. B. et al. Clock-like mutational processes in human somatic cells. Nat. Genet. 47, 1402–1407 (2015).
pubmed: 26551669 pmcid: 4783858 doi: 10.1038/ng.3441
Moore, L. et al. The mutational landscape of human somatic and germline cells. Nature 597, 381–386 (2021).
pubmed: 34433962 doi: 10.1038/s41586-021-03822-7
Privitera, A. P., Barresi, V. & Condorelli, D. F. Aberrations of chromosomes 1 and 16 in breast cancer: a framework for cooperation of transcriptionally dysregulated genes. Cancers https://doi.org/10.3390/cancers13071585 (2021).
Cancer Genome Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70 (2012).
doi: 10.1038/nature11412
Pereira, B. et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat. Commun. 7, 11479 (2016).
pubmed: 27161491 pmcid: 4866047 doi: 10.1038/ncomms11479
McNally, S. & Stein, T. Overview of mammary gland development: a comparison of mouse and human. Methods Mol. Biol. 1501, 1–17 (2017).
pubmed: 27796946 doi: 10.1007/978-1-4939-6475-8_1
Marshall, W. A. & Tanner, J. M. Variations in pattern of pubertal changes in girls. Arch. Dis. Child. 44, 291–303 (1969).
pubmed: 5785179 pmcid: 2020314 doi: 10.1136/adc.44.235.291
Rye, I. H. et al. Quantitative multigene FISH on breast carcinomas identifies der(1;16)(q10;p10) as an early event in luminal A tumors. Genes Chromosom. Cancer 54, 235–248 (2015).
pubmed: 25546585 doi: 10.1002/gcc.22237
Ciriello, G. et al. Comprehensive molecular portraits of invasive lobular breast cancer. Cell 163, 506–519 (2015).
pubmed: 26451490 pmcid: 4603750 doi: 10.1016/j.cell.2015.09.033
Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117 (2010).
pubmed: 20981102 pmcid: 3148940 doi: 10.1038/nature09515
Mitchell, T. J. et al. Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal. Cell 173, 611–623 e617 (2018).
pubmed: 29656891 pmcid: 5927631 doi: 10.1016/j.cell.2018.02.020
Williams, N. et al. Life histories of myeloproliferative neoplasms inferred from phylogenies. Nature 602, 162–168 (2022).
pubmed: 35058638 doi: 10.1038/s41586-021-04312-6
Coorens, T. H. H. et al. Embryonal precursors of Wilms tumor. Science 366, 1247–1251 (2019).
pubmed: 31806814 pmcid: 6914378 doi: 10.1126/science.aax1323
Moore, L. et al. The mutational landscape of normal human endometrial epithelium. Nature 580, 640–646 (2020).
pubmed: 32350471 doi: 10.1038/s41586-020-2214-z
Grossmann, S. et al. Development, maturation, and maintenance of human prostate inferred from somatic mutations. Cell Stem Cell 28, 1262–1274 e1265 (2021).
pubmed: 33657416 pmcid: 8260206 doi: 10.1016/j.stem.2021.02.005
Ramakrishnan, R., Khan, S. A. & Badve, S. Morphological changes in breast tissue with menstrual cycle. Mod. Pathol. 15, 1348–1356 (2002).
pubmed: 12481017 doi: 10.1097/01.MP.0000039566.20817.46
Navarrete, M. A. et al. Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle. Breast Cancer Res. 7, R306–313 (2005).
pubmed: 15987425 pmcid: 1143573 doi: 10.1186/bcr994
Cox, D. B., Kent, J. C., Casey, T. M., Owens, R. A. & Hartmann, P. E. Breast growth and the urinary excretion of lactose during human pregnancy and early lactation: endocrine relationships. Exp. Physiol. 84, 421–434 (1999).
pubmed: 10226182 doi: 10.1111/j.1469-445X.1999.01807.x
Figueroa, J. D. et al. Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. J. Natl. Cancer Inst. https://doi.org/10.1093/jnci/dju286 (2014).
Harbeck, N. et al. Breast cancer. Nat. Rev. Dis. Primers 5, 66 (2019).
pubmed: 31548545 doi: 10.1038/s41572-019-0111-2
Loibl, S., Poortmans, P., Morrow, M., Denkert, C. & Curigliano, G. Breast cancer. Lancet 397, 1750–1769 (2021).
pubmed: 33812473 doi: 10.1016/S0140-6736(20)32381-3
Britt, K., Ashworth, A. & Smalley, M. Pregnancy and the risk of breast cancer. Endocr. Relat. Cancer 14, 907–933 (2007).
pubmed: 18045947 doi: 10.1677/ERC-07-0137
No authors listed. The World Health Organization Multinational Study of Breast-feeding and Lactational Amenorrhea. II. Factors associated with the length of amenorrhea. Fertil. Steril. 70, 461–471 (1998).
doi: 10.1016/S0015-0282(98)00191-5
Yoshida, K. et al. Tobacco smoking and somatic mutations in human bronchial epithelium. Nature 578, 266–272 (2020).
pubmed: 31996850 pmcid: 7021511 doi: 10.1038/s41586-020-1961-1
Elston, C. W. & Ellis, I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19, 403–410 (1991).
pubmed: 1757079 doi: 10.1111/j.1365-2559.1991.tb00229.x
Lakhani, S. R., Ellis, I. O., Schnitt S. J., Tan P. H. & van de Vijver M. J. WHO Classification of Tumours of the Breast 4th edn (IARC, 2012).
Wong, S. M., King, T., Boileau, J. F., Barry, W. T. & Golshan, M. Population-based analysis of breast cancer incidence and survival outcomes in women diagnosed with lobular carcinoma in situ. Ann. Surg. Oncol. 24, 2509–2517 (2017).
pubmed: 28455673 doi: 10.1245/s10434-017-5867-6
Tischler, G. & Leonard, S. biobambam: tools for read pair collation based algorithms on BAM files. Source Code Biol. Med. 9, 13 (2014).
pmcid: 4075596 doi: 10.1186/1751-0473-9-13
Lim, E. et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 15, 907–913 (2009).
pubmed: 19648928 doi: 10.1038/nm.2000
Wong, C. M. et al. Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics 5, 645–655 (2010).
pubmed: 20716965 pmcid: 3052848 doi: 10.4161/epi.5.7.12961
Dekkers, J. F. et al. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nat. Protoc. 16, 1936–1965 (2021).
pubmed: 33692550 pmcid: 8221035 doi: 10.1038/s41596-020-00474-1
Mihara, E. et al. Active and water-soluble form of lipidated Wnt protein is maintained by a serum glycoprotein afamin/alpha-albumin. eLife https://doi.org/10.7554/eLife.11621 (2016).
Uehiro, N. et al. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Breast Cancer Res. 18, 129 (2016).
pubmed: 27993161 pmcid: 5168705 doi: 10.1186/s13058-016-0788-z
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
pubmed: 19451168 pmcid: 2705234 doi: 10.1093/bioinformatics/btp324
Conway, T. et al. Xenome–a tool for classifying reads from xenograft samples. Bioinformatics 28, i172–178 (2012).
pubmed: 22689758 pmcid: 3371868 doi: 10.1093/bioinformatics/bts236
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
pubmed: 19505943 pmcid: 2723002 doi: 10.1093/bioinformatics/btp352
Chen, Z. et al. Systematic comparison of somatic variant calling performance among different sequencing depth and mutation frequency. Sci. Rep. 10, 3501 (2020).
pubmed: 32103116 pmcid: 7044309 doi: 10.1038/s41598-020-60559-5
McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
pubmed: 20644199 pmcid: 2928508 doi: 10.1101/gr.107524.110
Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591–594 (2018).
pubmed: 30013048 doi: 10.1038/s41592-018-0051-x
Shiraishi, Y. et al. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data. Nucleic Acids Res. 41, e89 (2013).
pubmed: 23471004 pmcid: 3627598 doi: 10.1093/nar/gkt126
Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
pubmed: 20601685 pmcid: 2938201 doi: 10.1093/nar/gkq603
Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996–1006 (2002).
pubmed: 12045153 pmcid: 186604 doi: 10.1101/gr.229102
Thorvaldsdottir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 14, 178–192 (2013).
pubmed: 22517427 doi: 10.1093/bib/bbs017
Boeva, V. et al. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics 28, 423–425 (2012).
pubmed: 22155870 doi: 10.1093/bioinformatics/btr670
Scrucca, L., Fop, M., Murphy, T. B. & Raftery, A. E. mclust 5: clustering, classification and density estimation using Gaussian finite mixture models. R J 8, 289–317 (2016).
pubmed: 27818791 pmcid: 5096736 doi: 10.32614/RJ-2016-021
Tamura, K., Stecher, G. & Kumar, S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol 38, 3022–3027 (2021).
pubmed: 33892491 pmcid: 8233496 doi: 10.1093/molbev/msab120
Gillis, S. & Roth, A. PyClone-VI: scalable inference of clonal population structures using whole genome data. BMC Bioinf. 21, 571 (2020).
doi: 10.1186/s12859-020-03919-2
Manders, F. et al. MutationalPatterns: the one stop shop for the analysis of mutational processes. BMC Genomics 23, 134 (2022).
pubmed: 35168570 pmcid: 8845394 doi: 10.1186/s12864-022-08357-3
Bergstrom, E. N. et al. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events. BMC Genomics 20, 685 (2019).
pubmed: 31470794 pmcid: 6717374 doi: 10.1186/s12864-019-6041-2
Islam, S. M. A. et al. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genom. https://doi.org/10.1016/j.xgen.2022.100179 (2022).
Teh, Y. W., Jordan, M. I., Beal, M. J. & Blei, D. M. Hierarchical Dirichlet processes. J. Am. Stat. Assoc. 101, 1566–1581 (2006).
doi: 10.1198/016214506000000302
Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 17, 31 (2016).
pubmed: 26899170 pmcid: 4762164 doi: 10.1186/s13059-016-0893-4
Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029–1041 e1021 (2017).
pubmed: 29056346 pmcid: 5720395 doi: 10.1016/j.cell.2017.09.042
Borgan, Ø. Modeling Survival Data: Extending the Cox Model. Terry M. Therneau and Patricia M. Grambsch, Springer-Verlag, New York, 2000. No. of pages: xiii + 350. Price: $69.95. ISBN 0-387-98784-3. Stat. Med. 20, 2053–2054 (2001).
doi: 10.1002/sim.956
Nishimura, T., Kakiuchi, N. & Ogawa, S. Custom R scripts and input files for manuscript ‘Evolutionary histories of breast cancer and related clones’. Zenodo https://doi.org/10.5281/zenodo.8015913 (2023).

Auteurs

Tomomi Nishimura (T)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Next-generation Clinical Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Nobuyuki Kakiuchi (N)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
The Hakubi Center for Advanced Research, Kyoto University, Kyoto, Japan.
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Kenichi Yoshida (K)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan.

Takaki Sakurai (T)

Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
Department of Diagnostic Pathology, Osaka Red Cross Hospital, Osaka, Japan.

Tatsuki R Kataoka (TR)

Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
Department of Pathology, Iwate Medical University, Iwate, Japan.

Eiji Kondoh (E)

Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Obstetrics and Gynecology Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Yoshitsugu Chigusa (Y)

Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Masahiko Kawai (M)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Morio Sawada (M)

Adachi Hospital, Kyoto, Japan.

Takuya Inoue (T)

Adachi Hospital, Kyoto, Japan.

Yasuhide Takeuchi (Y)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.

Hirona Maeda (H)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.

Satoko Baba (S)

Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Yusuke Shiozawa (Y)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Ryunosuke Saiki (R)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Masahiro M Nakagawa (MM)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Next-generation Clinical Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Yasuhito Nannya (Y)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Yotaro Ochi (Y)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Tomonori Hirano (T)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.

Tomoe Nakagawa (T)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.

Yukiko Inagaki-Kawata (Y)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Kosuke Aoki (K)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Masahiro Hirata (M)

Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.

Kosaku Nanki (K)

Department of Organoid Medicine, Sakaguchi Laboratory, Keio University School of Medicine, Tokyo, Japan.

Mami Matano (M)

Department of Organoid Medicine, Sakaguchi Laboratory, Keio University School of Medicine, Tokyo, Japan.

Megumu Saito (M)

Department of Organoid Medicine, Sakaguchi Laboratory, Keio University School of Medicine, Tokyo, Japan.
Osaka Research Center for Drug Discovery, Otsuka Pharmaceutical Company, Limited, Osaka, Japan.

Eiji Suzuki (E)

Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Breast Surgery Department, Kobe City Medical Center General Hospital, Hyogo, Japan.

Masahiro Takada (M)

Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Masahiro Kawashima (M)

Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Kosuke Kawaguchi (K)

Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Kenichi Chiba (K)

Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.

Yuichi Shiraishi (Y)

Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.

Junko Takita (J)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Satoru Miyano (S)

Department of Integrated Analytics, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.
Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Masaki Mandai (M)

Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Toshiro Sato (T)

Department of Organoid Medicine, Sakaguchi Laboratory, Keio University School of Medicine, Tokyo, Japan.

Kengo Takeuchi (K)

Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Hironori Haga (H)

Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.

Masakazu Toi (M)

Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Seishi Ogawa (S)

Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. sogawa-tky@umin.ac.jp.
Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan. sogawa-tky@umin.ac.jp.
Department of Medicine, Centre for Haematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden. sogawa-tky@umin.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH